FMC vs IOSP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FMC Corporation is in a state of critical financial distress, evidenced by a Piotroski F-Score of 1/9 and a catastrophic 5-year price decline of 85.2%. While the stock appears cheap on a Price-to-Book (0.90) and Price-to-Sales (0.54) basis, these are classic 'value trap' indicators given the severe negative profit margin of -64.57% and an unsustainable dividend payout ratio of 223.08%. High leverage (Debt/Equity of 2.00) combined with declining revenue growth (-11.5% YoY) suggests significant operational instability.
IOSP presents as a financially stable, defensive value play with a Piotroski F-Score of 4/9 and an exceptionally clean balance sheet. While the stock trades almost exactly at its Graham Number ($74.99), suggesting fair defensive value, it trades at a significant premium to its growth-based intrinsic value ($32.69). The company demonstrates a strong track record of earnings beats, but this is offset by negative revenue growth and bearish insider sentiment. Overall, the lack of growth catalysts and poor long-term price performance temper the appeal of its strong solvency.
Compare Another Pair
Related Comparisons
FMC vs IOSP: Head-to-Head Comparison
This page compares FMC Corporation (FMC) and Innospec Inc. (IOSP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.